The ‘tau’ of cognition: Imaging suggests protein clumps could be Alzheimer’s biomarkers

Researchers from Washington University in St. Louis have used advanced imaging to reveal that a protein in the brain known as tau is suggestive of a patient’s cognitive function, according to results of a study recently published in Science Translational Medicine.

Recent advancements in the development of imaging agents allowed researchers to vizualize tangled tau protein clumps during neurological PET scans in the brains of 46 test subjects.

Patients with normal cognitive function showed minimal tau tangles throughout the brain, while those with cognitive impairment showed a substantial increase in the amount of the protein present in the temporal lobes and cerebral cortex.

Read more at the link below:

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.